Biotech · Private company
Paratek Pharmaceuticals Inc
Track this companyFree. Adds Paratek Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials153 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- linezolidPhase 3 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- LinezolidPhase 3 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- moxifloxacinPhase 3 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 3 · Bacterial PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- OmadacyclinePhase 3 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- OmadacyclinePhase 3 · Bacterial PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- PTK 0796Phase 3 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- LinezolidPhase 2 · Infectious Skin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Nitrofurantoin capsulesPhase 2 · Uncomplicated Urinary Tract InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Omadacycline Oral TabletPhase 2 · Mycobacterium Infections, NontuberculousClinicalTrials.gov · fetched Nov 12, 2026
- Omadacycline tabletsPhase 2 · Uncomplicated Urinary Tract InfectionClinicalTrials.gov · fetched Nov 12, 2026
- PTK 0796Phase 2 · Infectious Skin DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OmadacyclinePhase 1 · Community-acquired PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- Omadacycline Injection [Nuzyra]Phase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Omadacycline Oral TabletPhase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- Omadacycline for Treatment Refractory Mycoplasma Genitalium UrethritisPHASE2 · NOT_YET_RECRUITING · started Jan 1, 2027ClinicalTrials.gov NCT07853742 · fetched Nov 12, 2026
- Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal PolypsPHASE3 · RECRUITING · started Jul 28, 2025ClinicalTrials.gov NCT06850805 · fetched Nov 12, 2026
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint InfectionPHASE2 · ACTIVE_NOT_RECRUITING · started May 9, 2023ClinicalTrials.gov NCT05753215 · fetched Nov 12, 2026
- Effects of Intravenous (IV) Omadacycline on Gut MicrobiomePHASE4 · COMPLETED · started Mar 20, 2023ClinicalTrials.gov NCT05515562 · fetched Nov 12, 2026
- Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial InfectionsPHASE1 · COMPLETED · started Apr 6, 2022ClinicalTrials.gov NCT05217537 · fetched Nov 12, 2026
- Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)PHASE2 · COMPLETED · started Oct 15, 2021ClinicalTrials.gov NCT04922554 · fetched Nov 12, 2026
- Pharmacokinetics of Omadacycline in Cystic FibrosisPHASE4 · COMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT04460586 · fetched Nov 12, 2026
- Microbiome Effect of Omadacycline on Healthy VolunteersPHASE1 · COMPLETED · started Oct 12, 2020ClinicalTrials.gov NCT06030219 · fetched Nov 12, 2026
- Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial PneumoniaPHASE1 · COMPLETED · started Nov 28, 2019ClinicalTrials.gov NCT04160260 · fetched Nov 12, 2026
- OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal PolypsPHASE3 · COMPLETED · started Dec 31, 2018ClinicalTrials.gov NCT03747458 · fetched Nov 12, 2026
- Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of CystitisPHASE2 · COMPLETED · started Jan 4, 2018ClinicalTrials.gov NCT03425396 · fetched Nov 12, 2026
- Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)PHASE3 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02531438 · fetched Nov 12, 2026
- Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)PHASE3 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02378480 · fetched Nov 12, 2026
- Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)PHASE3 · TERMINATED · started Apr 4, 2009ClinicalTrials.gov NCT00865280 · fetched Nov 12, 2026
- Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)PHASE2 · COMPLETED · started Jul 18, 2007ClinicalTrials.gov NCT03716024 · fetched Nov 12, 2026